Table 2

Multivariate predictors of major adverse cardiac events

	HR	95% CI	p Value
Multivariate analysis
Model A (Clinical characteristics, treatments and LV parameters) AIC=453.006
Age	1.020	0.990 to 1.052	0.187
PCI	0.386	0.193 to 0.772	0.007
Nicorandil	0.243	0.098 to 0.597	0.002
LVEF^*	0.609	0.451 to 0.824	0.001
Model B (Clinical characteristics, treatments and MIBG parameters) AIC=426.402
Age	1.004	0.973 to 1.037	0.298
PCI	0.430	0.229 to 0.807	0.009
Nicorandil	0.325	0.129 to 0.816	0.017
WR^*	4.091	2.756 to 6.074	<0.001
Model C (Clinical characteristics, treatments, LV and MIBG parameters) AIC=455.004
Age	1.005	0.972 to 1.037	0.315
PCI	0.428	0.228 to 0.806	0.010
Nicorandil	0.319	0.125 to 0.814	0.016
LVEF^*	0.961	0.707 to 1.535	0.337
WR^*	5.339	3.152 to 9.041	<0.001

↵* Per 1 SD increase.
AIC, Akaike information criterion; LVEF, left ventricular ejection fraction; MIBG, m-iodobenzylguanidine; PCI, percutaneous coronary intervention; WR, washout rate.